Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
MultiCode®-RTx Technology – What is it?
We get a lot of questions about what exactly our MultiCode®-RTx Technology is and how it makes our ARIES® Systems sample to answer powerhouses. In a nutshell, our MultiCode-RTx is a probe-free, real-time polymerase chain reaction (PCR) technology.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
September 11
Luminex Corporation Declares Third Quarter Cash Dividend
September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results
July 13
Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018
World Vaccine Congress
29-31 October
Lisbon, Portugal
xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands
